Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Central Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06436144
What this trial is testing

Osimertinib and Etoposide as First-Line Treatment in Osimertinib-Resistant Advanced EGFR-Mutant NSCLC

Who this might be right for
Non Small Cell Lung CancerEGFR Gene MutationNon Small Cell Lung Cancer Stage IIIB+1 more
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 93
Testing effectiveness (Phase 2)Ended earlyNCT03666728
What this trial is testing

SHR-1210 in Combination With BP102 in Subjects With Non-squamous NSCLC

Who this might be right for
Lung Neoplasms
Jiangsu HengRui Medicine Co., Ltd. 5
Testing effectiveness (Phase 2)UnknownNCT05578222
What this trial is testing

Pembrolizumab as First-line Treatment for Advanced NSCLC Complicated With COPD

Who this might be right for
NSCLC With COPD
Tianjin Chest Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT06467500
What this trial is testing

A Prospective, Open-label, Single-center, Single-arm Phase II Clinical Study of Cadonilimab (AK104) Combined With Monotherapy Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer With Negative Driver Genes and Failed Immunotherapy

Who this might be right for
Non-small Cell Lung Cancer
Xin-Hua Xu 48
Not applicableStudy completedNCT01808430
What this trial is testing

Powered Echelon Device in VATS Surgery

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Ethicon Endo-Surgery (Europe) GmbH 158
Testing effectiveness (Phase 2)Study completedNCT03736837
What this trial is testing

Study of Anlotinib Combined With Icotinib as the First-line Treatment in Patients With EGFR Mutation-positive NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 60
Testing effectiveness (Phase 2)Study completedNCT03837977
What this trial is testing

Second-line Therapy for Patients With Progressive Poorly Differentiated Extra-pulmonary Neuroendocrine Carcinoma

Who this might be right for
OncologyNeuroendocrine Carcinoma
The Christie NHS Foundation Trust 58
Not applicableUnknownNCT04005157
What this trial is testing

ENB Guided MWA for Early-stage Peripheral Lung Cancer

Who this might be right for
Lung Cancer
Shanghai Chest Hospital 60
Testing effectiveness (Phase 2)UnknownNCT04467801
What this trial is testing

Ipatasertib and Docetaxel in Metastatic NSCLC Patients Who Have Failed 1st Line Immunotherapy

Who this might be right for
NSCLC Stage IVNSCLC Stage IIIB
Jun Zhang, MD, PhD 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07282873
What this trial is testing

Study of TYK-01054 Capsules in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor MalignanciesMalignant Mesothelioma (MM)
TYK Medicines, Inc 219
Not applicableUnknownNCT06220305
What this trial is testing

DNA Methylation Combined With Artificial Intelligence Imaging to Identify Lung Nodules

Who this might be right for
Lung Cancer Diagnosis
The First Affiliated Hospital with Nanjing Medical University 100
Large-scale testing (Phase 3)UnknownNCT03288870
What this trial is testing

Efficacy, Safety and Pharmacokinetics of BCD-100 (Anti-PD-1) Monotherapy as Second Line Treatment in Patients With Non-Small Cell Lung Cancer (DOMINUS)

Who this might be right for
Non Small Cell Lung Cancer Stage IIIBNon-Small Cell Carcinoma of Lung, TNM Stage 4
Biocad 218
Not applicableUnknownNCT05168254
What this trial is testing

Clinical and Multiomics Study of First-line Chemotherapy for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma, PDAC
Ruijin Hospital 50
Not applicableLooking for participantsNCT05835570
What this trial is testing

Integrin αvβ6-targeted PET in Malignant Tumors

Who this might be right for
Malignant NeoplasmPET/CTNon-Small Cell Lung Cancer+1 more
Zhongnan Hospital 200
Not applicableLooking for participantsNCT06634979
What this trial is testing

Selective Lymph Node Resection for Invasive Non-small Cell Lung Cancer With the CTR of 0.5-1 and the Diameter of ≤ 2 cm

Who this might be right for
Lung Cancer (NSCLC)Lymph Node Dissection
Fudan University 684
Not applicableLooking for participantsNCT07624318
What this trial is testing

TROP2 NMR Concordance Study

Who this might be right for
Lung Cancer
AstraZeneca 3,400
Testing effectiveness (Phase 2)Study completedNCT03704688
What this trial is testing

Trial of Trametinib and Ponatinib in Patients With KRAS Mutant Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung CancerKRAS Gene Mutation
Memorial Sloan Kettering Cancer Center 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT04516070
What this trial is testing

Stereotactic Radiosurgery for the Treatment of Patients With Small Cell Lung Cancer Brain Metastasis

Who this might be right for
Metastatic Lung Small Cell CarcinomaMetastatic Malignant Neoplasm in the BrainStage IV Lung Cancer AJCC v8+2 more
M.D. Anderson Cancer Center 55
Large-scale testing (Phase 3)Looking for participantsNCT05429463
What this trial is testing

Neoadjuvant Therapy of Sintilimab Combined With Chemotherapy for Resectable Squamous Cell NSCLC（neoSCORE Ⅱ）

Who this might be right for
Squamous Cell Non-small Cell Lung Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 250
Testing effectiveness (Phase 2)Study completedNCT06145048
What this trial is testing

Phase 2B Safety and Efficacy Study of VGT-309 in Subjects With Cancer in the Lung.

Who this might be right for
Lung CancerLung Metastases
Vergent Bioscience, Inc. 89
Next Page